Dataset from A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus

The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.

本研究将对比并评估罗格列酮（rosiglitazone）、二甲双胍（metformin）与格列本脲（glyburide/glibenclamide）单药长期治疗，对新近确诊的2型糖尿病（type 2 diabetes mellitus）患者血糖控制的改善与维持效果。